The "sosa" approach: An alternative to high-throughput screening

Medicinal Chemistry Research

Volumn 10, Issue 7-8, 2001, Pages 431-439

  Wermuth, Camille G ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BP 897; DRUG; FLOSEQUINAN; LEMAKALIM; MINAPRINE; NORFLOXACIN; PROPRANOLOL; SULPIRIDE;

ARTICLE; DRUG EFFECT; DRUG INDUSTRY; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG STRUCTURE; STRUCTURE ACTIVITY RELATION; TECHNIQUE;

EID: 0035695149     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Search for new lead compounds: The example of the chemical and pharmacological dissection of aminopyridazines
2. "Drug-like" leads: Bigger is not always better
3. 5-Hydroxytryptamine receptors and effector mechanisms in peripheral tissues
4. Radioautographic evidence that the GABA-A receptor antagonist SR 95531 is a substrate inhibitor of MAO-A in the rat and human locus coeruleus
5. Cyclic adenosine monophosphate phosphodiesterase in brain: Effect on anxiety
6. GABA receptor and ionophore binding sites: Interaction with various drugs
7. G-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists
8. Radioreceptor binding profile of the atypical antipsychotic olanzapine
9. Discovery and development of cromakalim and related potasssium channel activators
10. Cardiovascular effects of the novel arteriovenous dilator agent, flosequinan in conscious dogs and cats
11. SR 46559 A and related aminopyridazines are potent muscarinic agonists with no cholinergic syndrome
12. SR 46559A: A novel and potent muscarinic compound with no cholinergic syndrome
13. Aminopyridazines as acetylcholinesterase inhibitors
14. Design, synthesis and structure-activity relationships of a series of 3-[2-(1-benzylpiperidin-4-yl)ethylamino]pyridazine derivatives as acetylcholinesterase inhibitors
15. 3 receptor agonist